Does Rallies show 13F holders for IRWD?

Yes. Rallies tracks hedge fund and 13F ownership data for IRWD, including fund names, share counts, latest tracked quarter, and position changes when available.

Is IRWD research on Rallies investment advice?

No. Rallies provides research, data, and educational context for IRWD. It does not provide personalized investment advice.

IRWD (Ironwood Pharmaceuticals, Inc. - Class A) Stock Analysis - Hedge Fund Holdings

Ironwood Pharmaceuticals, Inc. - Class A (IRWD) is a publicly traded Healthcare sector company. As of May 21, 2026, IRWD trades at $3.85 with a market cap of $576.15M and a P/E ratio of 5.98. IRWD moved +6.81% today. Year to date, IRWD is -14.60%; over the trailing twelve months it is +500.86%. Its 52-week range spans $0.53 to $5.78. Analyst consensus is buy with an average price target of $7.50. Rallies surfaces IRWD's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.

Who owns IRWD stock?

Hedge funds tracked by Rallies that own IRWD include Panagora Asset and Farallon Capital. The latest tracked quarter is Dec 31, 2025. Rallies shows current holdings, share counts, position changes, and 13F ownership context for Ironwood Pharmaceuticals, Inc. - Class A.

IRWD Key Metrics

Key financial metrics for IRWD
Metric	Value
Price	$3.85
Market Cap	$576.15M
P/E Ratio	5.98
EPS	$0.64
Dividend Yield	0.00%
52-Week High	$5.78
52-Week Low	$0.53
Volume	5.04K
Avg Volume	0
Revenue (TTM)	$361.51M
Net Income	$102.18M
Gross Margin	0.00%

Top Hedge Funds Holding IRWD

Panagora Asset holds 54.41K shares of IRWD, changed -65.77% as of Dec 31, 2025.
Farallon Capital holds 13.00K shares of IRWD, changed +0.00% as of Mar 31, 2026.

Latest IRWD News

Ironwood Delivers $0.24 EPS in Q1, Tops Estimates After Prior-Year Loss — May 7, 2026
Ironwood Q4 Misses Estimates with 47.3% Revenue Drop and CNP-104 Setback — Feb 26, 2026
Ironwood Q4 EPS Loss of $0.01 Reverses Prior-Year Profit — Feb 25, 2026
Ironwood Pharmaceuticals Shares Up 129% Hold Top Analyst Ranking, Q4 Results Due Feb. 26 — Feb 13, 2026
Ironwood Lifts 2026 Revenue Forecast, Shares Jump 27% on LINZESS Demand — Jan 5, 2026

Recent IRWD Insider Trades

DENNER ALEXANDER J sold 6.72M (~$20.51M) on Mar 17, 2026.
DENNER ALEXANDER J sold 5.80K (~$19.20K) on Mar 17, 2026.
John Minardo sold 19.05K (~$69.73K) on Feb 24, 2026.

IRWD Analyst Consensus

3 analysts cover IRWD: 0 strong buy, 2 buy, 1 hold, 0 sell, 0 strong sell. Consensus rating is buy. Average price target: $7.50.

Common questions about IRWD

Who owns IRWD stock?: Hedge funds tracked by Rallies that own IRWD include Panagora Asset and Farallon Capital. The latest tracked quarter is Dec 31, 2025. Rallies shows current holdings, share counts, position changes, and 13F ownership context for Ironwood Pharmaceuticals, Inc. - Class A.
Does Rallies show 13F holders for IRWD?: Yes. Rallies tracks hedge fund and 13F ownership data for IRWD, including fund names, share counts, latest tracked quarter, and position changes when available.
Is IRWD research on Rallies investment advice?: No. Rallies provides research, data, and educational context for IRWD. It does not provide personalized investment advice.